BFRA
Income statement / Annual
Last year (2020), Biofrontera AG's total revenue was $30.35 M,
a decrease of 2.94% from the previous year.
In 2020, Biofrontera AG's net income was -$13.02 M.
See Biofrontera AG’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
| Operating Revenue |
$30.35 M
|
$31.27 M
|
$21.11 M
|
$12.03 M
|
$6.13 M
|
$4.14 M
|
$3.10 M
|
$3.11 M
|
$3.43 M
|
$515,296.49
|
| Cost of Revenue |
$3.54 M |
$4.88 M |
$4.45 M |
$1.72 M |
$1.65 M |
$1.24 M |
$1.12 M |
$1.60 M |
$1.51 M |
$444,884.14 |
| Gross Profit |
$26.81 M |
$26.39 M |
$16.66 M |
$10.31 M |
$4.48 M |
$2.90 M |
$1.98 M |
$1.51 M |
$1.92 M |
$70,412.35 |
| Gross Profit Ratio |
0.88 |
0.84 |
0.79 |
0.86 |
0.73 |
0.7 |
0.64 |
0.49 |
0.56 |
0.14 |
| Research and Development
Expenses |
$4.79 M
|
$4.64 M
|
$4.43 M
|
$4.23 M
|
$4.64 M
|
$6.20 M
|
$4.53 M
|
$3.19 M
|
$1.38 M
|
$1.40 M
|
| General & Administrative
Expenses |
$9.15 M
|
$16.28 M
|
$12.96 M
|
$3.10 M
|
$2.85 M
|
$2.76 M
|
$3.12 M
|
$5.46 M
|
$4.09 M
|
$0.00
|
| Selling & Marketing
Expenses |
$20.48 M
|
$28.86 M
|
$17.74 M
|
$16.92 M
|
$8.76 M
|
$4.17 M
|
$3.85 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$29.63 M
|
$45.13 M
|
$30.71 M
|
$20.02 M
|
$11.62 M
|
$6.93 M
|
$6.97 M
|
$5.46 M
|
$4.09 M
|
$0.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$3.04 M |
| Operating Expenses |
$34.42 M |
$49.77 M |
$35.13 M |
$24.24 M |
$16.26 M |
$13.13 M |
$11.51 M |
$8.65 M |
$5.48 M |
$4.44 M |
| Cost And Expenses |
$37.96 M |
$54.64 M |
$39.59 M |
$25.96 M |
$17.91 M |
$14.37 M |
$12.62 M |
$10.25 M |
$6.98 M |
$4.89 M |
| Interest Income |
$411,000.00 |
$127,000.00 |
$24,000.00 |
$38,000.00 |
$2,935.14 |
$9,225.68 |
$190,294.10 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$3.08 M |
$2.71 M |
$1.78 M |
$1.13 M |
$1.21 M |
$1.17 M |
$1.29 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$5.33 M
|
$3.16 M
|
$754,000.00
|
$884,000.00
|
$830,779.04
|
$811,681.84
|
$811,005.00
|
$742,133.19
|
$643,290.37
|
$361,821.44
|
| EBITDA |
-$4.28 M
|
$804,000.00
|
-$16.73 M
|
-$14.09 M
|
-$8.54 M
|
-$9.22 M
|
-$8.62 M
|
-$7.32 M
|
-$3.46 M
|
-$4.28 M
|
| EBITDA Ratio |
-0.14 |
0.03 |
-0.79 |
-1.17 |
-1.39 |
-2.23 |
-2.78 |
-2.35 |
-1.01 |
-8.31 |
| Operating Income Ratio
|
-0.25
|
-0.75
|
-0.88
|
-1.16
|
-1.92
|
-2.47
|
-3.08
|
-2.29
|
-1.04
|
-8.49
|
| Total Other
Income/Expenses Net |
-$5.09 M
|
$18.60 M
|
-$791,000.00
|
-$2.17 M
|
$1.20 M
|
-$972,456.91
|
-$1.19 M
|
-$928,877.91
|
-$550,161.46
|
-$270,092.52
|
| Income Before Tax |
-$12.70 M |
-$4.78 M |
-$19.27 M |
-$16.10 M |
-$10.58 M |
-$11.20 M |
-$10.72 M |
-$8.07 M |
-$4.10 M |
-$4.64 M |
| Income Before Tax Ratio
|
-0.42
|
-0.15
|
-0.91
|
-1.34
|
-1.73
|
-2.71
|
-3.46
|
-2.59
|
-1.2
|
-9.01
|
| Income Tax Expense |
$326,000.00 |
$2.58 M |
-$10.39 M |
-$1.04 M |
$2.41 M |
$196,094.51 |
$95,592.51 |
-$928,877.91 |
$15,262.80 |
-$270,092.52 |
| Net Income |
-$13.02 M |
-$7.64 M |
-$8.88 M |
-$16.10 M |
-$10.58 M |
-$11.20 M |
-$10.72 M |
-$8.07 M |
-$4.12 M |
-$4.64 M |
| Net Income Ratio |
-0.43 |
-0.24 |
-0.42 |
-1.34 |
-1.73 |
-2.71 |
-3.46 |
-2.59 |
-1.2 |
-9.01 |
| EPS |
-0.47 |
-0.33 |
-0.4 |
-0.78 |
-0.66 |
-0.78 |
-0.8 |
-0.59 |
-0.44 |
-0.69 |
| EPS Diluted |
-0.47 |
-0.33 |
-0.4 |
-0.78 |
-0.66 |
-0.78 |
-0.8 |
-0.59 |
-0.44 |
-0.69 |
| Weighted Average Shares
Out |
$27.83 M
|
$22.95 M
|
$22.44 M
|
$20.53 M
|
$16.03 M
|
$14.34 M
|
$13.47 M
|
$13.74 M
|
$9.29 M
|
$6.71 M
|
| Weighted Average Shares
Out Diluted |
$27.83 M
|
$22.95 M
|
$22.44 M
|
$20.53 M
|
$16.03 M
|
$14.34 M
|
$13.47 M
|
$13.74 M
|
$9.29 M
|
$6.71 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
